Authentication protection software company Bio-key International has entered into an OEM agreement with healthcare IT software firm Caradigm, a joint venture between GE Healthcare and Microsoft.
Caradigm will sell Bio-key's fingerprint biometric technology with its single-sign-on (SSO) software. Caradigm SSO, formerly Sentillion Vergence, allows caregivers to rapidly access applications and patient data without signing on to each application.
Using Bio-key technology with Caradigm SSO, caregivers will be able to perform strong authentication using more than 30 available finger biometric readers, as well as those embedded in most personal computers. They will also be able to use other authentication methods such as one-time password tokens delivered to a mobile device or displayed on screen.
